Close Menu

NEW YORK – Natera said late on Thursday that it has priced the $250 million public stock offering announced earlier this week. The company is offering 4,166,666 shares of its common stock at a price of $60 per share.

The follow-on offering is expected to close on Sept. 15, subject to customary closing conditions.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.